Your browser doesn't support javascript.
loading
Endostatin in fibrosis and as a potential candidate of anti-fibrotic therapy.
Zhang, Zequn; Liu, Xi; Shen, Zhaolong; Quan, Jun; Lin, Changwei; Li, Xiaorong; Hu, Gui.
Afiliación
  • Zhang Z; Department of General Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Liu X; Department of General Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Shen Z; Department of General Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Quan J; Department of General Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Lin C; Department of General Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Li X; Department of General Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Hu G; Department of General Surgery, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Drug Deliv ; 28(1): 2051-2061, 2021 Dec.
Article en En | MEDLINE | ID: mdl-34595978

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis / Endostatinas / Factor de Crecimiento Transformador beta1 Tipo de estudio: Prognostic_studies Idioma: En Revista: Drug Deliv Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fibrosis / Endostatinas / Factor de Crecimiento Transformador beta1 Tipo de estudio: Prognostic_studies Idioma: En Revista: Drug Deliv Asunto de la revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido